Tag - vaccines

 
Menu
Search
 
July 17, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

VACCINES

Japan Times
WORLD / Science & Health
Nov 26, 2020
After admitting error, AstraZeneca faces hard questions on vaccine
Scientists said a series of irregularities and omissions in the way AstraZeneca initially disclosed the data have eroded their confidence in the reliability of the results.
Japan Times
JAPAN / Science & Health
Nov 25, 2020
Not so fast, Japan experts say, as COVID-19 vaccines raise hopes
Medical experts say long-term safety and efficacy concerns remain as the vaccines are developed in record-setting time.
Japan Times
WORLD / Science & Health / FOCUS
Nov 24, 2020
Decades of work, and half a dose of fortune, drove Oxford vaccine success
The Oxford vaccinologists were exhilarated on Monday when drugmaker AstraZeneca, with whom they developed the shot, announced that it could be around 90% effective.
Japan Times
WORLD / Politics
Nov 23, 2020
G20 vows fair distribution of COVID-19 vaccines to all nations
At the virtual summit, Prime Minister Yoshihide Suga emphasized the importance of guaranteeing universal access by supplying treatment drugs and vaccines for COVID-19.
Japan Times
WORLD
Nov 23, 2020
U.S. plans first vaccinations in weeks, Operation Warp Speed chief says
Vaccinations against COVID-19 in the U.S. will "hopefully” start in less than three weeks, according to the head of the federal government’s program to accelerate a vaccine.
Japan Times
WORLD / Science & Health
Nov 21, 2020
Two companies say their vaccines are 95% effective. What does that mean?
You might assume that 95 out of every 100 people vaccinated will be protected from COVID-19. But that's not how the math works.
Japan Times
WORLD / Science & Health
Nov 19, 2020
Can first vaccines bring herd immunity? Experts have doubts.
Figuring out what's needed to achieve herd immunity with COVID-19 vaccines involves a range of factors, several of which are unknown.
Japan Times
WORLD / Science & Health
Nov 19, 2020
Pfizer-BioNTech coronavirus vaccine deliveries could start 'before Christmas'
Final trial results showed the vaccine had a 95% success rate and no serious side effects, the drugmakers said.
Japan Times
ASIA PACIFIC / Science & Health
Nov 18, 2020
China takes risk in rushing to use unproven coronavirus vaccines
China has made its unproven candidates widely available to demonstrate their safety and effectiveness to a country that has long been skeptical of vaccines.
Japan Times
ASIA PACIFIC / Science & Health
Nov 18, 2020
Sinovac's COVID-19 vaccine induces quick immune response, study finds
Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.
Japan Times
WORLD / Science & Health
Nov 18, 2020
Pfizer reaches safety milestone for COVID-19 vaccine, CEO says
Pfizer Inc. Chief Executive Officer Albert Bourla said that a key safety milestone had been reached in the study of its COVID-19 vaccine, and the drugmaker is now preparing to seek an emergency-use authorization from U.S. regulators.
Japan Times
WORLD / Science & Health / FOCUS
Nov 18, 2020
How Pfizer and BioNTech sprinted ahead in extraordinary race for a COVID-19 vaccine
Researchers were asked to tackle something that had never been done before: design a vaccine to stop a pandemic in its tracks in less than a year.
Japan Times
WORLD / Science & Health
Nov 17, 2020
Moderna’s COVID-19 vaccine: What you need to know
Coming a week after similar news from Pfizer and BioNTech, Moderna's announcement offered more hope that there's going to be a way out of the pandemic.
Japan Times
WORLD / Science & Health
Nov 17, 2020
WHO warns against COVID-19 complacency after Moderna vaccine news
'Right now we are extremely concerned by the surge in cases we are seeing in some countries,' WHO director-general Tedros Adhanom Ghebreyesus told a news briefing.
Japan Times
WORLD / Science & Health
Nov 17, 2020
How the Moderna and Pfizer coronavirus vaccines stack up
The encouraging late-stage trial results from Pfizer Inc. and Moderna Inc. set a high bar for rivals that are expected to follow soon with their own pivotal reports.
Japan Times
WORLD
Nov 16, 2020
Drugmaker Moderna says COVID-19 vaccine shows nearly 95% protection
A key advantage of Moderna's vaccine is that it does not need ultracold storage like Pfizer's, making it easier to distribute.
Japan Times
ASIA PACIFIC
Nov 13, 2020
China under pressure to reveal vaccine data after Pfizer success
While Beijing has hailed the progress on its own own COVID-19 vaccines, it has so far yet to back this up with evidence.
Japan Times
WORLD / Science & Health
Nov 12, 2020
Moderna COVID-19 vaccine trial reaches key goal to gauge merit
The bet among top experts in the field is that Moderna's therapy will likely prove to be highly effective.
Japan Times
WORLD / Science & Health
Nov 12, 2020
Russia says its Sputnik V COVID-19 vaccine is 92% effective
Experts welcomed the news but warned that the results were only based on a small number of trial volunteers who had contracted COVID-19.
Japan Times
WORLD / Science & Health
Nov 12, 2020
Brazil says Chinese vaccine trial can resume after suspension
Brazil health regulator Anvisa on Wednesday allowed resumption of late-stage Brazilian clinical trials for China's Sinovac COVID-19 vaccine, which had been suspended due to a study subject's death that was registered in Sao Paulo as a suicide.
South Korea couple beat same-sex barriers to parenthood
South Korean lesbian couple Kim Kyu-jin (left) and her wife, Kim Sae-yeon, pose with a "pregnant woman" badge during an interview in Seoul last month.
Japan unveils new overtourism countermeasures
The majority of tourists in Japan tend to stay in Tokyo, Osaka or Kyoto, resulting in overcrowding in popular tourist spots and a strain on transportation systems.
Opportunities await the bold in the Year of the Wood Dragon
2024 marks the Year of the Dragon in the Chinese zodiac, with the year predicted to be a good time for fresh starts.
Japan pharma startup developing world-first drug to grow new teeth
A new tooth is seen in a ferret's mouth after it was administered a drug to stimulate the growth of tooth buds.
Don’t worry about global population collapse
Most projections show the world will hit peak humanity in the 21st century as people choose to have smaller families and women gain power over their own reproduction.
The neurological disorder that 'kills culture'
Akiko Trush says her experience with the neurological disorder dystonia left her feeling like she wanted to chop her own hand off.
How to beat Japan’s summer heat in ways better for the planet
Tenugui towels hang up to dry at a dyeing company in Sakai, Osaka Prefecture, on May 8. The durable and versatile tenugui, which many people have in their homes, can be used in many ways to cool one’s body.
After Trump shooting, U.S. presidential race might take a violent turn
United States Secret Service Counter Snipers stand guard on a rooftop during a campaign rally for U.S. President Donald Trump in Avoca, Pennsylvania, in 2020.
No AC this summer? No problem (for me).
Think air conditioning is a requirement for a Tokyo summer? Think again.
She’s paying ¥1 million to help behind the scenes at the Paris Olympics
Mai Tarumi, who previously volunteered at the postponed Tokyo Olympics in 2021, has a travel budget of ¥1 million for her trip to volunteer at the Paris Games.

Podcast

You can often see generations of families enjoying performances together at Fuji Rock Festival.
Japan’s summer music festivals are feeling the heat in more ways than one

Longform

Akiko Trush says her experience with the neurological disorder dystonia left her feeling like she wanted to chop her own hand off.
The neurological disorder that 'kills culture'
By Tomoko Otake

SUSTAINABLE JAPAN

Exploring Japanese culturevia Tohoku’s festivals
Exploring Japanese culturevia Tohoku’s festivals

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER